XML 48 R32.htm IDEA: XBRL DOCUMENT v3.25.2
Note 2 - Summary of Significant Accounting Policies (Details Textual)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 05, 2025
USD ($)
Mar. 20, 2020
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Oct. 22, 2021
USD ($)
Accounts Receivable, Allowance for Credit Loss, Current $ 0   $ 134,000   $ 134,000   $ 97,000  
Inventory Valuation Reserves     0   0   0  
Asset Conversion, Accounts Receivable to Notes Receivable $ 3,764,000       3,764,000 $ 0    
Asset Conversion, Interest Rate 10.00%              
Financing Receivable, after Allowance for Credit Loss $ 3,572,000              
Number of Patents Acquired               3
Income (Loss) from Equity Method Investments     7,000 $ (1,000) 9,000 $ (1,000)    
Customer Deposit Liability, Current     158,000   158,000   90,000  
Unrecognized Tax Benefits     $ 0   $ 0      
Operating Lease, Weighted Average Discount Rate, Percent     18.00%   18.00%      
Operating Lease, Right-of-Use Asset     $ 937,000   $ 937,000   992,000  
Operating Lease, Liability     977,000   977,000   1,027,000  
Finance Lease, Right-of-Use Asset, after Accumulated Amortization     $ 418,000   $ 418,000   451,000  
Minimum [Member]                
Property, Plant and Equipment, Useful Life (Year)     3 years   3 years      
Maximum [Member]                
Property, Plant and Equipment, Useful Life (Year)     10 years   10 years      
Canadian Government Grants [Member] | Minimum [Member]                
Grant Term (Month)         6 months      
Canadian Government Grants [Member] | Maximum [Member]                
Grant Term (Month)         18 months      
ONM [Member]                
Customer Deposit Liability, Current     $ 77,000   $ 77,000   14,000  
CANADA                
Customer Deposit Liability, Current     81,000   $ 81,000   76,000  
Share-Based Payment Arrangement, Option [Member]                
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares         60,653,962      
Warrant [Member]                
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares         29,727,446      
Odin Co Ltd [Member]                
Payments to Acquire Interest in Joint Venture   $ 100,000            
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage   40.00%            
Odin Co Ltd [Member] | Tomorrow Water [Member]                
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage   30.00%            
Odin Co Ltd [Member] | BKT and Tomorrow Water [Member]                
Payments to Acquire Interest in Joint Venture   $ 150,000            
Clyra Medical Technologies [Member]                
Finance Lease, Right-of-Use Asset, after Accumulated Amortization     418,000   $ 418,000   451,000  
Finance Lease, Liability     $ 405,000   $ 405,000   $ 448,000  
Subsidiary, Ownership Percentage, Noncontrolling Owner     50.00%   50.00%   48.00%  
BioLargo Engineering, Science & Technologies, LLC [Member]                
Subsidiary, Ownership Percentage, Noncontrolling Owner     26.00%   26.00%   26.00%  
BioLargo Energy Technologies, Inc (BETI) [Member]                
Subsidiary, Ownership Percentage, Noncontrolling Owner     4.00%   4.00%   4.00%  
Patents [Member]                
Intangible Assets, Net (Excluding Goodwill), Total               $ 34,000
Customer Concentration Risk [Member] | Accounts Receivable [Member]                
Number of Major Customers         1      
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]                
Number of Major Customers             1